Developer docs
API playgroundTry for free, no card

Search company profiles

Brain Navi Biotechnology

Full company profile

uuid0005t9k

Namestring
Brain Navi Biotechnology
Legal namestring
Brain Navi Biotechnology Co., Ltd.
Websiteurl
brainnavi.com
Company typeenum
Private
Founded yearint
2015
Short descriptiontext

Brain Navi Biotechnology is a Taiwan-based surgical robotics company that develops and markets the NaoTrac autonomous neurosurgical navigation robot and KrystoLens single-use neuro-endoscope, serving neurosurgery departments in hospitals across Asia, Europe, and the Americas.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHsinchu, Taiwan
HQ citystring
Hsinchu
HQ countrystring
Taiwan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurosurgical navigation robot, robotic neurosurgery system, single-use neuro-endoscope, machine vision surgical navigation, minimally invasive neurosurgery
Industry4 codes
1Surgical Robotics & Computer-Assisted Surgery Platforms
CodeHLAHADAFPrimaryYes
2Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
CodeHLAHADAGPrimaryNo
3Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
CodeHLAHADABPrimaryNo
4Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
CodeHLAHADAHPrimaryNo
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Robotics - Neurosurgical Navigation
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1NaoTrac Surgical Navigation Robot Sales
TypeHardware Sales
Description

Sale of NaoTrac autonomous neurosurgical navigation robot systems to hospitals and medical centers

prnewswire.com
2KrystoLens Consumables
TypeHardware Sales
Description

Single-use disposable neuro-endoscope product line generating recurring consumable revenue

brainnavi.com
3Service and Support
TypeProfessional Services
Description

Installation, training, and ongoing technical support services for NaoTrac system

brainnavi.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Medical device enterprise sales - custom quotation
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. Direct enterprise sales to hospitals.

prnewswire.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1NaoTrac
Description

Autonomous neurosurgical navigation robot using machine vision and 3D positioning for brain surgery navigation.

brainnavi.com
+2 more records
Core offering1 text field

Brain Navi Biotechnology designs, manufactures, and sells robotic neurosurgical navigation systems and neuro-endoscopes for hospital neurosurgery departments. Its flagship product NaoTrac is an autonomous neurosurgical navigation robot that uses machine vision and the proprietary SMART (Surface Mapping Auto-registration Technology) platform to enable non-contact patient registration and sub-millimeter surgical pathway navigation through 1cm keyhole incisions. Its complementary product KrystoLens is the first single-use 2D/3D neuro-endoscope for intracranial visualization, sold as a recurring disposable consumable.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Patient registration time reduced from 49.1 minutes to 2.4 minutes
+6 more records
Product overview1 text field

Brain Navi Biotechnology is a surgical robotics company offering a portfolio of neurosurgical products centered on two main platforms: NaoTrac (autonomous surgical navigation robot) and KrystoLens (single-use neuro-endoscope), both built on the proprietary SMART (Surface Mapping Auto-registration Technology) platform. NaoTrac provides AI-powered surgical navigation with machine vision-based patient registration, while KrystoLens offers disposable endoscopic visualization. The products serve hospitals and surgical centers performing neurosurgical procedures including brain tumor biopsies, deep brain stimulation, EVD placement, ICH treatment, and stem cell implantation.

Product and service3 records
1NaoTrac Surgical Navigation Robot
CategoryNeurosurgical Navigation Robot
Description

Autonomous neurosurgical navigation robot for hospital neurosurgery departments. Uses machine vision and the proprietary SMART (Surface Mapping Auto-registration Technology) platform to enable non-contact patient registration and autonomously navigate to lesion targets through 1-centimeter keyhole incisions, achieving sub-0.5mm registration accuracy. Supports brain tumor biopsy, deep brain stimulation, EVD placement, ICH evacuation, and stereotactic neurosurgery.

2KrystoLens Single-Use Neuro-Endoscope
CategorySingle-Use Neuro-Endoscope
Description

First single-use 2D/3D disposable neuro-endoscope with a wide-angle surgical working channel (8.5mm x 4.7mm) for intracranial surgery visualization. Designed for ventriculostomies, biopsies, removal of cysts, tumors, and other obstructions, providing dual-lens 3D view to neurosurgeons.

3AOARM Educational Training Platform
CategorySurgical Robotics Training & Education
Description

Educational training platform linked from Brain Navi's product menu for surgeon training and continuing education on the NaoTrac neurosurgical navigation system.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierStrategicTypeGTM or Marketing PartnerAnnounced on2026-01-16
Description

MOU with City of Phoenix, Greater Phoenix Economic Council, and Tesoro Venture Capital to strengthen cross-border collaboration in AI, semiconductors, and health-tech startups. Part of Taiwan-U.S. innovation link initiative building on TSMC expansion in Phoenix.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-05-01
Description

Spain distribution partner for NaoTrac market entry in Europe. Led successful first NaoTrac surgeries in Spain and ongoing commercialization efforts in Spanish market.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-03-20
Description

Strategic partnership to introduce and commercialize NaoTrac neurosurgical navigation robot in the Chinese market. BenQ Medical Technology leverages its extensive hospital network across China for clinical deployment. Supported by China's 14th Five-Year Plan for Medical Equipment Industry development.

Strategic tierSecondaryTypeTechnology or IntegrationAnnounced on2025-03-01
Description

Technology partnership using Avalue Healthcare's Medical Edge AI PC MAB-T600 to enable real-time 3D imaging, robotic-assisted navigation, and AI-driven machine vision capabilities.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Selected for prestigious medical technology accelerator program. Provides access to clinical expertise, research capabilities, and US market development support through Mayo Clinic and Arizona State University partnership.

6Bestchain HealthTaiwan
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-01-01
Description

General distributor partnership covering Taiwan market. Part of Bestchain Medical Group for comprehensive distribution of Brain Navi products in Taiwan.

brainnavi.com
Strategic tierSecondaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-01-01
Description

Boise-based partner for sales and marketing efforts in the United States medical device market. MOU signed for further sales cooperation.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Key clinical partner for first-in-human trial (2018) and ongoing clinical research. Published pilot study results in Acta Neurochirurgica journal on EVD placement using NaoTrac SMART technology.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Medtronic's StealthStation is the dominant incumbent in image-guided neurosurgical navigation. While much broader in portfolio, StealthStation competes head-to-head with NaoTrac for neurosurgery hospital procurement and represents the legacy bone-fiducial-based paradigm Brain Navi is disrupting.

TypeEmerging player
Description

Penumbra's REAL Immersive System is a robotic-assisted neurosurgery navigation platform with partial overlap to NaoTrac. Both are emerging players pursuing workflow-disrupting neurosurgical navigation, with Penumbra leveraging a strong neurovascular commercial channel.

TypeDirect peer
Description

Brainlab offers the Curve and Kick navigation systems used widely in neurosurgery ORs globally. Direct overlap with NaoTrac in surgical navigation for cranial procedures; comparable in targeting neurosurgery departments with image-guided workflow solutions.

TypeDirect peer
Description

Renishaw's neuromate system is one of the closest direct competitors — a dedicated stereotactic neurosurgical robot used for biopsy, DBS, and SEEG. Comparable in being a focused, capital-equipment neurosurgical navigation/robotics player targeting hospital neurosurgery departments.

TypeDirect peer
Description

Synaptive's Modus V and BrightMatter platforms combine neurosurgical navigation, robotics, and visualization — a near-perfect analog of Brain Navi's NaoTrac + KrystoLens pairing. Both target precision neurosurgery with workflow-enhancing technology for hospitals.

TypeDirect peer
Description

Karl Storz is the established leader in rigid neuro-endoscopy — directly comparable to Brain Navi's KrystoLens single-use neuro-endoscope line. Both target neurosurgical visualization, though Karl Storz leads in reusable scopes while KrystoLens is differentiated as a single-use 3D platform.

TypeBroad incumbent
Description

Stryker is a broad incumbent offering neurosurgical navigation, surgical instruments, and visualization (including neuro-endoscopy via acquired assets). Comparable in targeting the neurosurgery OR with an integrated hardware-and-consumables portfolio.

TypeEmerging player
Description

Globus Medical's ExcelsiusGPS is an image-guided robotic navigation platform with growing cranial applications. Comparable as a smaller, focused surgical robotics competitor to NaoTrac in image-guided neurosurgery, with overlapping hospital procurement channels.

TypeRegional player
Description

THINK Surgical develops open-platform surgical robotics for orthopedic procedures; methodologically comparable as a focused, independent surgical robotics company with a similar capital-equipment-plus-consumables business model, though primarily US-focused and orthopedic rather than neurosurgical.

TypeDirect peer
Description

Zimmer Biomet's ROSA platform includes a ROSA Brain module for neurosurgical procedures — a directly comparable robotic neurosurgery assistant. Comparable business model selling robotic capital equipment to hospitals and competing for the same neurosurgery budget line.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Brain Navi Biotechnology

Surgical Robotics - Neurosurgical Navigationbrainnavi.com

Brain Navi Biotechnology is a Taiwan-based surgical robotics company that develops and markets the NaoTrac autonomous neurosurgical navigation robot and KrystoLens single-use neuro-endoscope, serving neurosurgery departments in hospitals across Asia, Europe, and the Americas.

Brain Navi Biotechnology firmographics

Firmographics
Name
Brain Navi Biotechnology
Legal name
Brain Navi Biotechnology Co., Ltd.
Website
https://brainnavi.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Brain Navi Biotechnology is a Taiwan-based surgical robotics company that develops and markets the NaoTrac autonomous neurosurgical navigation robot and KrystoLens single-use neuro-endoscope, serving neurosurgery departments in hospitals across Asia, Europe, and the Americas.
Ownership category
akta.pro rank

Brain Navi Biotechnology industry classification

Industry
Product category
Surgical Robotics - Neurosurgical Navigation
NAICS
Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
akta.pro secondary industries
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)

Keywords

  • Neurosurgical navigation robot
  • Robotic neurosurgery system
  • Single-use neuro-endoscope
  • Machine vision surgical navigation
  • Minimally invasive neurosurgery

Where Brain Navi Biotechnology is headquartered

Location

Headquarters

HQ city
Hsinchu
HQ country
Taiwan
HQ region
Asia

Offices1 record

Markets served

Brain Navi Biotechnology business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. NaoTrac Surgical Navigation Robot Sales: Sale of NaoTrac autonomous neurosurgical navigation robot systems to hospitals and medical centers
  2. KrystoLens Consumables: Single-use disposable neuro-endoscope product line generating recurring consumable revenue
  3. Service and Support: Installation, training, and ongoing technical support services for NaoTrac system

Pricing tiers

ModelBillingPrice
OtherMulti-year contractMedical device enterprise sales - custom quotation

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Brain Navi Biotechnology product offering

Product offering

Core offering

Brain Navi Biotechnology designs, manufactures, and sells robotic neurosurgical navigation systems and neuro-endoscopes for hospital neurosurgery departments. Its flagship product NaoTrac is an autonomous neurosurgical navigation robot that uses machine vision and the proprietary SMART (Surface Mapping Auto-registration Technology) platform to enable non-contact patient registration and sub-millimeter surgical pathway navigation through 1cm keyhole incisions. Its complementary product KrystoLens is the first single-use 2D/3D neuro-endoscope for intracranial visualization, sold as a recurring disposable consumable.

Product overview

Brain Navi Biotechnology is a surgical robotics company offering a portfolio of neurosurgical products centered on two main platforms: NaoTrac (autonomous surgical navigation robot) and KrystoLens (single-use neuro-endoscope), both built on the proprietary SMART (Surface Mapping Auto-registration Technology) platform. NaoTrac provides AI-powered surgical navigation with machine vision-based patient registration, while KrystoLens offers disposable endoscopic visualization. The products serve hospitals and surgical centers performing neurosurgical procedures including brain tumor biopsies, deep brain stimulation, EVD placement, ICH treatment, and stem cell implantation.

Differentiator

Problem solved

Functional benefit

Brands

  • NaoTrac: Autonomous neurosurgical navigation robot using machine vision and 3D positioning for brain surgery navigation.
  • KrystoLens
  • SMART Technology

Products and services

  • NaoTrac Surgical Navigation Robot Autonomous neurosurgical navigation robot for hospital neurosurgery departments. Uses machine vision and the proprietary SMART (Surface Mapping Auto-registration Technology) platform to enable non-contact patient registration and autonomously navigate to lesion targets through 1-centimeter keyhole incisions, achieving sub-0.5mm registration accuracy. Supports brain tumor biopsy, deep brain stimulation, EVD placement, ICH evacuation, and stereotactic neurosurgery.
  • KrystoLens Single-Use Neuro-Endoscope First single-use 2D/3D disposable neuro-endoscope with a wide-angle surgical working channel (8.5mm x 4.7mm) for intracranial surgery visualization. Designed for ventriculostomies, biopsies, removal of cysts, tumors, and other obstructions, providing dual-lens 3D view to neurosurgeons.
  • AOARM Educational Training Platform Educational training platform linked from Brain Navi's product menu for surgeon training and continuing education on the NaoTrac neurosurgical navigation system.

Quantifiable outcome

  • Patient registration time reduced from 49.1 minutes to 2.4 minutes
  • +6 more outcomes

Companies that use Brain Navi Biotechnology

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Brain Navi Biotechnology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature7 records

Brain Navi Biotechnology partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered strategic, core, secondary and flagship.

  • Startup Island TAIWANstrategicGTM or Marketing Partner · 16 January 2026MOU with City of Phoenix, Greater Phoenix Economic Council, and Tesoro Venture Capital to strengthen cross-border collaboration in AI, semiconductors, and health-tech startups. Part of Taiwan-U.S. innovation link initiative building on TSMC expansion in Phoenix.
  • Palex HealthcarecoreChannel Partner/ Reseller/ Distributor · 1 May 2025Spain distribution partner for NaoTrac market entry in Europe. Led successful first NaoTrac surgeries in Spain and ongoing commercialization efforts in Spanish market.
  • BenQ Medical TechnologycoreChannel Partner/ Reseller/ Distributor · 20 March 2025Strategic partnership to introduce and commercialize NaoTrac neurosurgical navigation robot in the Chinese market. BenQ Medical Technology leverages its extensive hospital network across China for clinical deployment. Supported by China's 14th Five-Year Plan for Medical Equipment Industry development.
  • Avalue HealthcaresecondaryTechnology or Integration · 1 March 2025Technology partnership using Avalue Healthcare's Medical Edge AI PC MAB-T600 to enable real-time 3D imaging, robotic-assisted navigation, and AI-driven machine vision capabilities.
  • Mayo Clinic and ASU MedTech AcceleratorflagshipStrategic or Co-development Partner · 1 January 2024Selected for prestigious medical technology accelerator program. Provides access to clinical expertise, research capabilities, and US market development support through Mayo Clinic and Arizona State University partnership.
  • Bestchain HealthTaiwancoreChannel Partner/ Reseller/ Distributor · 1 January 2022General distributor partnership covering Taiwan market. Part of Bestchain Medical Group for comprehensive distribution of Brain Navi products in Taiwan.
  • SMHeuristicssecondaryChannel Partner/ Reseller/ Distributor · 1 January 2019Boise-based partner for sales and marketing efforts in the United States medical device market. MOU signed for further sales cooperation.
  • Hualien Tzu-Chi Medical CentercoreStrategic or Co-development Partner · 1 January 2018Key clinical partner for first-in-human trial (2018) and ongoing clinical research. Published pilot study results in Acta Neurochirurgica journal on EVD placement using NaoTrac SMART technology.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Brain Navi Biotechnology competitors and assessment

Company assessment

Broad incumbents

  • Medtronic (StealthStation): Medtronic's StealthStation is the dominant incumbent in image-guided neurosurgical navigation. While much broader in portfolio, StealthStation competes head-to-head with NaoTrac for neurosurgery hospital procurement and represents the legacy bone-fiducial-based paradigm Brain Navi is disrupting.
  • Stryker: Stryker is a broad incumbent offering neurosurgical navigation, surgical instruments, and visualization (including neuro-endoscopy via acquired assets). Comparable in targeting the neurosurgery OR with an integrated hardware-and-consumables portfolio.

Emerging players

  • Penumbra (REAL System): Penumbra's REAL Immersive System is a robotic-assisted neurosurgery navigation platform with partial overlap to NaoTrac. Both are emerging players pursuing workflow-disrupting neurosurgical navigation, with Penumbra leveraging a strong neurovascular commercial channel.
  • Globus Medical (ExcelsiusGPS): Globus Medical's ExcelsiusGPS is an image-guided robotic navigation platform with growing cranial applications. Comparable as a smaller, focused surgical robotics competitor to NaoTrac in image-guided neurosurgery, with overlapping hospital procurement channels.

Direct peers

  • Brainlab: Brainlab offers the Curve and Kick navigation systems used widely in neurosurgery ORs globally. Direct overlap with NaoTrac in surgical navigation for cranial procedures; comparable in targeting neurosurgery departments with image-guided workflow solutions.
  • Renishaw: Renishaw's neuromate system is one of the closest direct competitors — a dedicated stereotactic neurosurgical robot used for biopsy, DBS, and SEEG. Comparable in being a focused, capital-equipment neurosurgical navigation/robotics player targeting hospital neurosurgery departments.
  • Synaptive Medical: Synaptive's Modus V and BrightMatter platforms combine neurosurgical navigation, robotics, and visualization — a near-perfect analog of Brain Navi's NaoTrac + KrystoLens pairing. Both target precision neurosurgery with workflow-enhancing technology for hospitals.
  • Karl Storz: Karl Storz is the established leader in rigid neuro-endoscopy — directly comparable to Brain Navi's KrystoLens single-use neuro-endoscope line. Both target neurosurgical visualization, though Karl Storz leads in reusable scopes while KrystoLens is differentiated as a single-use 3D platform.
  • Zimmer Biomet (ROSA Robotics): Zimmer Biomet's ROSA platform includes a ROSA Brain module for neurosurgical procedures — a directly comparable robotic neurosurgery assistant. Comparable business model selling robotic capital equipment to hospitals and competing for the same neurosurgery budget line.

Regional players

  • THINK Surgical: THINK Surgical develops open-platform surgical robotics for orthopedic procedures; methodologically comparable as a focused, independent surgical robotics company with a similar capital-equipment-plus-consumables business model, though primarily US-focused and orthopedic rather than neurosurgical.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Brain Navi Biotechnology social profiles

Digital presence

Brain Navi Biotechnology compliance and trust

Trust signal

Compliance6 records

Brain Navi Biotechnology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Brain Navi Biotechnology leadership team

Management profile

Number of profiles

Profiles8 records

Brain Navi Biotechnology funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Brain Navi Biotechnology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brain Navi Biotechnology

What does Brain Navi Biotechnology do?

Brain Navi Biotechnology designs, manufactures, and sells robotic neurosurgical navigation systems and neuro-endoscopes for hospital neurosurgery departments. Its flagship product NaoTrac is an autonomous neurosurgical navigation robot that uses machine vision and the proprietary SMART (Surface Mapping Auto-registration Technology) platform to enable non-contact patient registration and sub-millimeter surgical pathway navigation through 1cm keyhole incisions. Its complementary product KrystoLens is the first single-use 2D/3D neuro-endoscope for intracranial visualization, sold as a recurring disposable consumable.

Is Brain Navi Biotechnology a public or private company?

Brain Navi Biotechnology is a private company. It is classified as venture growth investor backed and is currently operating.

When was Brain Navi Biotechnology founded?

Brain Navi Biotechnology was founded in 2015. It employs 11 to 50 people.

Where is Brain Navi Biotechnology based?

Brain Navi Biotechnology is headquartered in Hsinchu, Taiwan, in the Asia region.

How does Brain Navi Biotechnology make money?

Three revenue lines are on record. NaoTrac Surgical Navigation Robot Sales are the primary driver. The others are krystoLens Consumables and service and Support.

Who are Brain Navi Biotechnology's main competitors?

Broad incumbents on record are Medtronic (StealthStation) and Stryker. Emerging players are Penumbra (REAL System) and Globus Medical (ExcelsiusGPS). Direct peers are Brainlab, Renishaw, Synaptive Medical, Karl Storz and Zimmer Biomet (ROSA Robotics). THINK Surgical is listed as a regional player.

Does Brain Navi Biotechnology have an API?

No public API is recorded for Brain Navi Biotechnology.

What industry is Brain Navi Biotechnology in?

Brain Navi Biotechnology's product category is Surgical Robotics - Neurosurgical Navigation. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBeyond the Millimeter: NaoTrac Redefines Precision Standards via Intelligent Surgical NavigationBrain Navi Biotechnology has developed NaoTrac, a neurosurgical navigation robot that uses machine vision and 3D positioning to assist brain surgery, requiring no bone fiducials and operating through 1-centimeter keyhole incisions. The system reduces patient registration time from 49.1 minutes to 2.4 minutes and has received regulatory approvals including TFDA, CE, FDA, and CDSCO. The technology aims to make neurosurgery more precise while flattening the learning curve for younger surgeons through its semi-autonomous collaborative model.PR NewswireBeyond the Millimeter: NaoTrac Redefines Precision Standards via Intelligent Surgical NavigationBrain Navi Biotechnology's NaoTrac is a neurosurgical navigation robot that uses machine vision and 3D positioning to detect over 300,000 facial checkpoints without bone fiducials. Clinical data shows it reduces patient registration time from 49.1 minutes to 2.4 minutes and enables ultra-minimally invasive 1-centimeter incisions. The system holds FDA, CE, and other approvals.BrainnaviThe Future Has Reached the Present In NeurosurgicalBrain Navi is introducing the NaoTrac surgical navigation robot, which integrates machine vision and AI-driven algorithms to enhance precision and efficiency in neurosurgical interventions. The system features automated patient registration via facial recognition and an open-platform design that allows surgeons to use their preferred instruments while maintaining full control.PR NewswireBrain Navi Biotechnology's NaoTrac performs first surgeries in SpainBrain Navi Biotechnology has officially entered the Spanish market through a partnership with Palex Healthcare, successfully completing the first neurosurgical procedures using its NaoTrac navigation robot at a Spanish hospital. The milestone was achieved within a week of showcasing the technology at the SENEC Congress, Spain's leading annual neurosurgery conference, where surgeons expressed strong interest in the AI-powered surgical system. This marks Brain Navi's continued global expansion, reinforcing its mission to improve patient outcomes through advanced medical robotics.GreyBTop 5 Surgery Robot Startups to Watch in 2025This article profiles five innovative startups developing robot-assisted surgery solutions, highlighting companies based in China, India, Hong Kong, and Taiwan working on various surgical robotics technologies. The featured startups include Aibo Medical Robot ($32.9M funding), ROBO Medical (Series A), TAUREAN SURGICAL (Pre-Seed), Agilis Robotics ($6M Series A), and Brain Navi Biotechnology. These companies are addressing challenges in surgical robotics including high equipment costs, steep learning curves, and accessibility issues through innovations in vascular intervention, endoscopic surgery, neurosurgery, and autonomous surgical navigation.PR NewswireNavigating the Future of Neurosurgery: Brain Navi demonstrates NaoTrac and KrystoLens at CNS 2023 & EANS 2023Brain Navi Biotechnology demonstrated its neurosurgical navigation robot NaoTrac at CNS 2023 in Washington D.C. and its single-use neuro-endoscope KrystoLens at EANS 2023 in Barcelona, showcasing robotic-assisted surgery technology designed to reduce human error and improve patient recovery times through increased precision. The company reported that neurosurgeons from China Medical University Hospital and An-Nan Hospital in Taiwan shared positive clinical experiences, citing promising patient recovery outcomes and reduced surgical time. CEO Dr. Jerry Chen stated that Brain Navi aims to expand the technology to more clinics and hospitals worldwide as utilization of its installed base increases.PR NewswireEspecialistas bolivianos e taiwaneses discutem os mais recentes desenvolvimentos da Med-Tech para posicionar a Bolívia como um centro líder em neurocirurgia robóticaMedical specialists from Bolivia and Taiwan convened at the "The Future of Robotic Surgery" online conference in May 2023 to discuss surgical navigation robots and their potential to establish Bolivia as a leading center for robotic neurosurgery in South America. The discussions highlighted the NaoTrac neuro-surgical navigation robot developed by Taiwan's Brain Navi Biotechnology, which has received CE certification and local government approval, with three medical centers currently using it in Taiwan. Bolivia plans to create a robotic surgical training education center, potentially the first in South America, with ongoing collaboration between Bolivian and Taiwanese medical specialists.PR NewswireBrain Navi NaoTrac, der Neurochirurgische Navigationsroboter, erhält 2021 die europäische CE-ZulassungBrain Navi Biotechnology, a Taiwan-based startup specializing in surgical navigation robots, received CE approval in Q2 2021 for its NaoTrac neurosurgical navigation robot, with FDA approval as the next regulatory target. The NaoTrac uses the company's proprietary SMART (Surface Mapping Auto-Registration Technology) platform combining machine vision, robotics, and algorithms for real-time imaging and minimally invasive procedures. The company is pursuing expanded applications through an industry-academia partnership with Taiwan's Chenggong-Universität for liver ablation navigation and broader cancer treatment research.PR NewswireBrain Navi NaoTrac, le robot de navigation neurochirurgicale, a reçu le marquage CE en 2021Brain Navi Biotechnology received CE marking in the second quarter of 2021 for its NaoTrac surgical navigation robot, enabling its use in neurosurgical procedures. The company plans to submit an application for FDA approval next and is collaborating with the Chenggong University of Taiwan to expand the technology's applications to other medical fields such as liver treatments.PR NewswireBrain Navi NaoTrac recibió la aprobación de la marca CE europea en 2021Brain Navi Biotechnology, a Taiwan-based medical robotics company, received European CE marking approval in Q2 2021 for its NaoTrac cranial surgical navigation robot. The device uses artificial vision and proprietary SMART registration technology to enable precise, minimally invasive brain procedures while reducing surgery and anesthesia time. The company is now pursuing FDA approval and plans to showcase the technology at Healthcare Expo Taiwan 2021.